Verastem, Inc. Presents Data On Cancer Stem Cell-Targeting Agents At The 2014 American Association for Cancer Research Annual Meeting

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced the presentation of scientific data at the American Association for Cancer Research annual meeting being held April 5 - 9, 2014, at the San Diego Convention Center in San Diego, CA.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC